CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
dexamethasone is effective and safe when given to people who have multiple myeloma that has gotten worse and is not responding to s ...
Phase 2
Chicago, Illinois, United States
a registration, open-label phase 1 study of the combination of ibrutinib/lenalidomide:/dexamethasone in women and men with relapsed/refractory multiple...
Phase 1
Maywood, Illinois, United States and 4 other locations
(DRd) to that of lenalidomide and dexamethasone (Rd), in terms of progression-free survival in participants with relapsed or refractory multiple...
Phase 3
Chicago, Illinois, United States and 145 other locations
(BCMA)-specific chimeric antigen receptor (CAR) and manufactured with a new process. CAR-T cells will be investigated as a single agent in multiple...
Phase 1
Chicago, Illinois, United States and 12 other locations
The purpose of this study is to evaluate the safety and preliminary efficacy of CC-92480 in combination with standard treatments.
Phase 1, Phase 2
Chicago, Illinois, United States and 48 other locations
This study will be a multi-center, open-label, Phase 2 study where newly diagnosed Multiple Myeloma requiring systemic chemotherapy...
Phase 2
Chicago, Illinois, United States and 2 other locations
of these combinations in participants with relapsed or refractory multiple myeloma. The study will consist of 3 distinct parts: Par ...
Phase 2
Chicago, Illinois, United States and 40 other locations
A Phase 2, open-label, dose escalation study to evaluate the safety and efficacy of venetoclax in combination with carfilzomib-dexamethasone (Kd) in...
Phase 2
Chicago, Illinois, United States and 31 other locations
versus standard regimens in subjects with relapsed and refractory multiple myeloma (RRMM).The study is anticipated to randomize app...
Phase 3
Chicago, Illinois, United States and 59 other locations
progression-free survival (PFS) in participants with newly diagnosed multiple myeloma (a blood cancer of plasma cells) who are not ...
Phase 3
Chicago, Illinois, United States and 211 other locations
Clinical trials
Research sites
Resources
Legal